about
Cigarette smoking is a risk factor for Alzheimer's Disease: an analysis controlling for tobacco industry affiliationPain management in patients with dementiaSmoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studiesA claims data-based comparison of comorbidity in individuals with and without dementiaComorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data.Reduced clinical and postmortem measures of cardiac pathology in subjects with advanced Alzheimer's Disease.Dementia as a determinant of social and health service use in the last two years of life 1996-2003Role of vascular risk factors and vascular dysfunction in Alzheimer's disease.Type 2 diabetes is negatively associated with Alzheimer's disease neuropathologyDoes diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of Alzheimer's disease.Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative DiseasesTreatment of chronic pain in persons with dementia: an overview.Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program.Antemortem Prediction of Braak Stage.Diabetes and the elderly brain: sweet memories?Cardiac risk factors and potential treatments in Alzheimer's disease.Medical disorders in Alzheimer's disease and vascular dementia.A Cross-Sectional Analysis of Late-Life Cardiovascular Factors and Their Relation to Clinically Defined Neurodegenerative Diseases.Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing.The appropriateness of drug use in an older nondemented and demented population.Apolipoprotein-E genotyping of diabetic dementia patients: is diabetes rare in Alzheimer's disease?Charlson Comorbidity Index, inappropriate medication use and cognitive impairment : Bermuda Triangle.Rate of cognitive decline in preclinical Alzheimer's disease: the role of comorbidity.Plasma homocysteine and risk of coexisting silent brain infarction in Alzheimer's disease.Mental and psychological conditions, medical comorbidity and functional limitation: differential associations in older adults with cognitive impairment, depressive symptoms and co-existence of both.Discharge diagnosis and comorbidity profile in hospitalized older patients with dementia.Drug use patterns of persons with Alzheimer's disease and related disorders living in the community.Alzheimer patients report less pain intensity and pain affect than non-demented elderly.Undiagnosed diseases in patients with dementia--a potential target group for intervention.The Acute versus Chronic Pain Questionnaire (ACPQ) and actual pain experience in older people.Functional status and clinical correlates in cognitively impaired community-living older people.Prevalence of diseases in different dementias.Coexistence of Alzheimer's disease and diabetes mellitus.Uncertain diagnosis of an uncertain entity?Prevalence of associated diseases in different types of dementia among elderly institutionalized patients: analysis of 3447 records.The risk of dementia among persons with diabetes mellitus: a population-based cohort study.Diabetes and dementia in long-term care.Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia.Nicotinic system and Alzheimer's disease.Co-morbidity associated with dementia.
P2860
Q24606390-5EAC797A-9635-4580-B822-A7F8141AAB1BQ27024015-ECBD6D7C-3578-4A14-BB0F-E9AD8499837AQ28207349-9FAA8D14-B902-402E-A415-B85F9AD488B3Q30570359-3573D3CB-6292-4CF4-8370-4E13BAB9CA7CQ31160667-AD3C08FC-2EB7-4876-8BDE-26BBF515E61BQ33803397-140F42DA-C7DD-4649-AEFF-135714F483A6Q33864160-63A09DF9-9142-434B-9E30-E0E6FB59C33EQ34055011-85907CFB-51B3-46A8-A02D-F253B94948F8Q35184690-8599F941-08AE-440D-BF28-59C6F556CBFAQ35618911-296C72BA-EAB5-4A4E-B699-5E60F1BAA8BAQ35977445-F24B3C75-B980-4A3E-B170-57BA59517F4AQ36063652-673146D5-2DF6-415F-BBB5-F5692FCF394DQ36121377-9BD4A1ED-51E5-414A-8BA4-E5442311C7C9Q36175429-8C89CE5E-8E88-4A6A-836B-118A8010317FQ36515189-F5CD632D-4E38-403C-A943-DBDBC9D642D8Q36582769-F92EA505-ABD4-479C-B29D-6AE3E74652A0Q36682036-805FA8EE-7BF3-4456-A9C8-6E5A71A791E8Q37083632-7A8D7524-ECEE-4816-B908-27BEFBF8DA6BQ39487718-EA270FE4-7D7C-4DD4-A3B6-A1C616A17C91Q43573346-6CC6D90F-6967-47E6-8130-3DFF789A6BE6Q46088813-8C485194-77BB-4EFE-8580-228476603DC7Q47631220-BBEA3318-0014-490B-916A-64670D8A2080Q47739633-13565767-D32A-4780-A8BC-0EB3383066A4Q48447054-B30D5C43-52B6-4C76-8C81-A8E5E2FA3777Q50787543-95CE444C-18B3-4CBC-93A9-38656CB9F8CCQ50788564-72E8C3AE-63B1-47A4-978A-8AE917497C20Q51059750-18B9C4E8-040E-4914-8422-F2101DA3B0BDQ51083897-75D8065B-F043-4D38-ACAD-27D6313BBCACQ51938358-2DAE7EA8-093B-454C-9A73-88BF7A3833ECQ51953479-EE1021FF-24D5-49DC-BAA4-086F95ADB7A9Q51968119-55C3FAE2-F15A-4227-A27C-6C348E8BDF6DQ52878558-CB5A5D4B-7A27-496A-83F0-45300748BB50Q53179428-62B713BF-2E91-4117-A4CF-E8264084039EQ53181756-D3099445-D0AF-4E35-BCD1-7A593F418313Q53206034-289EB90B-1A29-42E1-A3EC-890A25450C85Q53219701-DFFB9BE4-6A96-4F44-871C-165EF0FA97C1Q53227860-CDA780C8-AEE5-4130-9124-7E472ED166D2Q53318360-26A1894F-03CD-4A44-B8C9-826A60338FFCQ53325579-BA5A4B47-C85E-4145-A232-63680B9003CAQ53352005-5DD1069B-62B1-4F59-8EA3-207DA52A60B8
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Are Alzheimer patients healthier?
@en
type
label
Are Alzheimer patients healthier?
@en
prefLabel
Are Alzheimer patients healthier?
@en
P2093
P2860
P1476
Are Alzheimer patients healthier?
@en
P2093
Siverstone FA
Termotto V
Wolf-Klein GP
P2860
P304
P356
10.1111/J.1532-5415.1988.TB01804.X
P407
P577
1988-03-01T00:00:00Z